Porton Pharma Solutions Ltd
SZSE:300363
Porton Pharma Solutions Ltd
Net Income (Common)
Porton Pharma Solutions Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
P
|
Porton Pharma Solutions Ltd
SZSE:300363
|
Net Income (Common)
¥879.5m
|
CAGR 3-Years
45%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Net Income (Common)
¥3.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Net Income (Common)
¥2.8B
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
21%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Net Income (Common)
¥4.2B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
2%
|
CAGR 10-Years
13%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Net Income (Common)
¥4.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Net Income (Common)
¥755.6m
|
CAGR 3-Years
36%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
See Also
What is Porton Pharma Solutions Ltd's Net Income (Common)?
Net Income (Common)
879.5m
CNY
Based on the financial report for Sep 30, 2023, Porton Pharma Solutions Ltd's Net Income (Common) amounts to 879.5m CNY.
What is Porton Pharma Solutions Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
46%
Over the last year, the Net Income (Common) growth was -49%. The average annual Net Income (Common) growth rates for Porton Pharma Solutions Ltd have been 45% over the past three years , 46% over the past five years .